Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided)

Per Soelberg Sørensen

doi:10.1177/1352458512451946

Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided)

Per Soelberg Sørensen

Afdeling for Hjerne- og Nervesygdomme NEU

2 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Multiple Sclerosis
Vol/bind	18
Udgave nummer	8
Sider (fra-til)	1070-2
Antal sider	3
ISSN	1352-4585
DOI	https://doi.org/10.1177/1352458512451946
Status	Udgivet - 2012

Adgang til dokumentet

10.1177/1352458512451946

Citationsformater

@article{6da09ffee79e4ec685e8cdd077b4dd81,

title = "Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided)",

keywords = "Antibodies, Monoclonal, Humanized, Disability Evaluation, Humans, Iatrogenic Disease, Immunologic Factors, Leukoencephalopathy, Progressive Multifocal, Multiple Sclerosis, Relapsing-Remitting, Patient Safety, Patient Selection, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome",

author = "S{\o}rensen, \{Per Soelberg\}",

year = "2012",

doi = "10.1177/1352458512451946",

language = "English",

volume = "18",

pages = "1070--2",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "Sage Publications Ltd",

number = "8",

}

TY - JOUR

T1 - Deaths and disability from natalizumab are no longer tolerable

T2 - No - (they can be avoided)

AU - Sørensen, Per Soelberg

PY - 2012

Y1 - 2012

KW - Antibodies, Monoclonal, Humanized

KW - Disability Evaluation

KW - Humans

KW - Iatrogenic Disease

KW - Immunologic Factors

KW - Leukoencephalopathy, Progressive Multifocal

KW - Multiple Sclerosis, Relapsing-Remitting

KW - Patient Safety

KW - Patient Selection

KW - Risk Assessment

KW - Risk Factors

KW - Time Factors

KW - Treatment Outcome

U2 - 10.1177/1352458512451946

DO - 10.1177/1352458512451946

M3 - Journal article

C2 - 22807471

SN - 1352-4585

VL - 18

SP - 1070

EP - 1072

JO - Multiple Sclerosis

JF - Multiple Sclerosis

IS - 8

ER -